Brian G Atwood Clovis Oncology, Inc. (CLVS) insider trading activity

CLVS Quotes by TradingView

Brian G Atwood is Director of Clovis Oncology, Inc.. Currently has a direct ownership of 32,758 shares of CLVS, which is worth approximately $2,948. The most recent transaction as insider was on Nov 09, 2020, when has been sold 6,896 shares (Common Stock) at a price of $3.08 per share, resulting in proceeds of $21,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.8K
0% 3M change
0% 12M change
Total Value Held $2,948

BRIAN G ATWOOD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 09 2020
BUY
Exercise of conversion of derivative security
$21,240 $3.08 p/Share
6,896 Added 17.39%
32,758 Common Stock

Also insider at

BCEL
Atreca, Inc. Healthcare
Director
EFTR
eFFECTOR Therapeutics, Inc. Healthcare
Director
PBAXU
PHOENIX BIOTECH ACQUISITION CORP. Financial Services
Chief Executive Officer
BGA

Brian G Atwood

Director
Philadelphia, PA

Track Institutional and Insider Activities on CLVS

Follow Clovis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

News

Receive news related to Clovis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLVS